Posted on: June 26, 2020
Chris Romeo, EVP of MedAxiom Ventures, speaks with Terry A. Colip and Dr. Veronica Covalesky about Cell>Point’s breakthrough cardiology ischemia agent, Oncardia®. As the first functional “hot spot” imaging agent delivered in a single “shake and shoot” vial, Oncardia® provides many clinical, economic and patient convenience benefits, including improved sensitivity and specificity, elimination of the stress test, lower radiation exposure and improved economics for the practice.
Unlock the full article by signing up for a FREE Guest Membership
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.